Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jiayang Sai"'
Autor:
Tian Xu, Xue Yu, Jing Ji, Qi Shao, Ying Li, Ting Li, Hanfen Shi, Huiling Tian, Jiayang Sai, Chongyang Ma, Xueqian Wang, Fafeng Cheng, Qingguo Wang
Publikováno v:
Pharmacological Research - Modern Chinese Medicine, Vol 3, Iss , Pp 100098- (2022)
Calculus bovis (CB), a famous traditional Chinese medicine, is commonly used to treat various inflammatory diseases, including oral ulcers. However, the potential mechanisms of CB in the treatment of oral ulcers are still limited. The present study a
Externí odkaz:
https://doaj.org/article/071dda032fb54251812be836992dddc7
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Millions of people are suffering from chronic pain conditions, such as headache, arthritis, cancer. Apart from western medicines, traditional Chinese medicines are also well accepted for pain management, especially in Asian countr
Externí odkaz:
https://doaj.org/article/8d27d13e40b3464aa1d036bf98f562a3
Autor:
Xiaoyi Wei, Weixin Hou, Jiajun Liang, Peng Fang, Bo Dou, Zisong Wang, Jiayang Sai, Tian Xu, Chongyang Ma, Qiuyun Zhang, Fafeng Cheng, Xueqian Wang, Qingguo Wang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in China. Sinisan (SNS) is a traditional Chinese medicine formula that has been widely used in treating chronic liver diseases, including NAFLD. However, its underl
Externí odkaz:
https://doaj.org/article/0b835993a7e14b24b93030def74fdd7c
Autor:
Tian Xu, Chongyang Ma, Qiuyun Zhang, Fafeng Cheng, Yuqiong Du, Lianyin Gao, Zisong Wang, Jiayang Sai, Kai Yan
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 2187-2202 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 1, Pp 2187-2202 (2021)
Nonalcoholic fatty liver disease (NAFLD) has become a major public health issue as its progression increases risks of multisystem morbidity and mortality. Recent evidence indicates a more complex relationship between hypertension and NAFLD than previ
Autor:
Jiayang Sai, Zisong Wang, Bo Dou, Weixin Hou, Tian Xu, Xiaoyi Wei, Chongyang Ma, Jiajun Liang, Fafeng Cheng, Qingguo Wang, Peng Fang, Xueqian Wang, Qiuyun Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in China. Sinisan (SNS) is a traditional Chinese medicine formula that has been widely used in treating chronic liver diseases, including NAFLD. However, its underl
Publikováno v:
Aging (Albany NY)
Overexpression of the miR-31-5p contributes to tumorigenesis and metastasis in diverse neoplasms. In this study, we evaluated expression of miR-31-5p in patients with colon adenocarcinoma (COAD). We found that miR-31-5p was overexpressed in four coho
Autor:
Jinjun Cheng, Huihua Qu, Qingguo Wang, Wenchao Shan, Jiayang Sai, Hui Kong, Yan Zhao, Baoping Qu
Publikováno v:
Journal of Fluorescence. 25:1371-1376
Previously, we developed an indirect competitive enzyme-linked immunosorbent assay (icELISA) for baicalin (BAL) and used this assay to investigate the pharmacokinetics of BAL in mice. In this study, an anti-BAL monoclonal antibody (MAb) was purified
Autor:
Wenchao Shan, Yue Zhang, Feng Huibin, Huihua Qu, Yan Wang, Jiayang Sai, Yan Zhao, Qingguo Wang
Publikováno v:
Journal of Chromatography B. 985:197-205
In this work, hybridomas producing anti-ginsenoside-Rh1 monoclonal antibodies (MAbs) were generated. These MAbs were subsequently used to create indirect competitive enzyme-linked immunosorbent assays (icELISAs). A linear correlation was obtained for
Publikováno v:
Analytical Methods. 7:3048-3053
Currently, little is known about how the dosage of one component of traditional Chinese medicine (TCM) alters the pharmacokinetic properties of the others in prescriptions. Banxia-Xiexin Decoction (BXD) consists of concentrated granules of seven Chin
Publikováno v:
Planta Medica. 80:1143-1150
This work describes an immunochemical approach for the quality control of Panax ginseng and a pharmacological study of ginsenoside Re, a major bioactive constituent in P. ginseng , using an enzyme-linked immunosorbent assay. A hybridoma secreting mon